Netherlands (NL)

General Framework for Randomized Benchmarking (2022) Helsen J, Roth , Onorati E, Werner AH, Eisert J Journal article LDHB Overexpression Can Partially Overcome T Cell Inhibition by Lactic Acid (2022) Decking SM, Bruss C, Babl N, Bittner S, Klobuch S, Thomas S, Feuerer M, et al. Journal article Label-free analytic histology of carotid atherosclerosis by mid-infrared optoacoustic microscopy (2022) Visscher M, Pleitez MA, Van Gaalen K, Nieuwenhuizen-Bakker IM, Ntziachristos V, Van Soest G Journal article Multispectral optoacoustic tomography for in vivo detection of lymph node metastases in oral cancer patients using an EGFR-targeted contrast agent and intrinsic tissue contrast: A proof-of-concept study (2022) Vonk J, Kukacka J, Steinkamp PJ, De Wit JG, Voskuil FJ, Hooghiemstra WTR, Bader M, et al. Journal article Can We Cluster ICU Treatment Strategies for Traumatic Brain Injury by Hospital Treatment Preferences? (2022) Ceyisakar IE, Huijben JA, Maas AIR, Lingsma HF, Van Leeuwen N Journal article A Usage-Based Approach to Pattern Finding: The Traceback Method Meets Code-Mixing (2022) Quick AE, Backus A Journal article MANAGEMENT OF REFERRALS, TREATMENT STRATEGY, AND RESEARCH CHALLENGES IN POLYMYALGIA RHEUMATICA AMONGST RHEUMATOLOGISTS WORLDWIDE: A QUESTIONNAIRE BASED STUDY (2022) Donskov AO, Mackie S, Hauge EM, Gutierrez CT, Hansen I, Hemmig A, Van Der Maas A, et al. Conference contribution PREDICTING OUTCOMES IN SYSTEMIC SCLEROSIS: STRATIFICATION BY AUTO-ANTIBODIES OUTPERFORMS CUTANEOUS SUBSETTING IN THE EUSTAR COHORT (2022) Elhai M, Boubaya M, Sritharan N, Balbir-Gurman A, Siegert E, Hachulla E, De Vries-Bouwstra J, et al. Conference contribution CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH SYSTEMIC SCLEROSIS SINE SCLERODERMA: DATA FROM THE INTERNATIONAL EUSTAR DATABASE. (2022) Lescoat A, Huang S, Carreira P, Siegert E, De Vries-Bouwstra J, Distler J, Smith V, et al. Conference contribution REDUCED JOINT SYNOVITIS ASSESSMENT VERSUS THE GLOBAL EULAR OMERACT SYNOVITIS SCORE (GLOESS) TO PREDICT THE RESPONSE TO SECUKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: EXPLORATORY RESULTS FROM THE ULTIMATE TRIAL (2022) D'Agostino MA, Boers M, Schett G, Conaghan PG, Naredo E, Mandl P, Carron P, et al. Conference contribution